New offering adds regional myocardial strain measurement and MyoHealth® Scores to the Advanced Heart Health Scan, now available at 17 U.S. Prenuvo clinics. The Advanced Heart Health Scan is available in eligible Prenuvo Executive Memberships or as a standalone screening.
RESEARCH TRIANGLE PARK, N.C., Aug. 24, 2026 /PRNewswire-PRWeb/ -- Myocardial Solutions, Inc., developer of the FDA-cleared MyoStrain® cardiac MRI software, today announced that its MyoStrain technology is used in the Advanced Heart Health Scan offered by Prenuvo, a leader in whole body MRI screening. The assessment provides MyoHealth® Scores and a calculated ejection fraction, offering standardized information about cardiac function that may support clinical interpretation, patient understanding, and tracking over time. The Advanced Heart Health Scan is available in eligible Prenuvo Executive Memberships and as a standalone screening.
"Myocardial health is emerging as one of the next major frontiers in preventive medicine across cardiovascular, metabolic, inflammatory and genetic conditions, cardiotoxicity from medical treatments, and age-related cardiovascular disease," said Dr. Rafael Rivero, Chief Medical Officer of Myocardial Solutions, Inc. "MyoStrain is a contrast-free MRI scan acquired in 12 heartbeats. Bringing it to Prenuvo's platform is a significant step forward for preventive cardiology and for our mission to reduce the global burden of cardiovascular disease for patients, their families, and health systems."
"We're thrilled to bring the MyoStrain technology to Prenuvo patients," said Dr. Dan Durand, Chief Medical Officer at Prenuvo. "Combining advanced cardiac assessment with whole body MRI gives us a more detailed picture of a person's health. By adding a quantitative view of myocardial function to the Prenuvo experience, we can help patients better understand their heart health in the context of their overall health, while making this type of advanced cardiac assessment more accessible."
About MyoStrain
MyoStrain measures myocardial strain, the deformation of the heart muscle as it contracts and relaxes with each beat across multiple regions of the left and right ventricles. MyoStrain summarizes these measurements in a MyoHealth® Score, a single, quantitative measure of the percentage of ventricular segments with normal intramyocardial contraction function, supporting clinical interpretation and monitoring over time.
MyoStrain uses a rapid, non-invasive, contrast-free cardiac MRI sequence (Fast-SENC) to provide standardized measurements of regional myocardial function that can be compared across repeat imaging.
What the Advanced Heart Health Scan Includes:
- MyoHealth® Scores, which use MyoStrain software to provide a standardized summary of cardiac muscle function
- Left and right ventricular ejection fractions, quantitatively measured from specialized cardiac MRI data
- MyoStrain regional myocardial strain measurement across multiple segments of the heart
- Information that may support clinical interpretation and discussion with a healthcare provider
- The ability to compare measurements over time when repeat imaging is available
Availability
The Advanced Heart Health Scan is available now as part of the Prenuvo Executive Membership and as a standalone screening in Los Angeles, New York City, Chicago, Atlanta, Boca Raton, Bethesda, Scottsdale, Houston, San Diego, Denver, Seattle, Minneapolis, Dallas, Miami, Pasadena, Irvine and Las Vegas. Pricing varies by clinic location. Booking is available at www.prenuvo.com/book.
About Myocardial Solutions, Inc.
Myocardial Solutions, Inc., headquartered in Research Triangle Park, North Carolina, developed MyoStrain® in conjunction with Johns Hopkins. MyoStrain is FDA-cleared cardiac MRI software that quantifies myocardial strain across regions of the left and right ventricles and reports results as a MyoHealth® Score, delivering reproducible measures of myocardial function through a rapid, contrast-free MRI acquisition. Learn more at myocardialsolutions.com.
About Prenuvo
Prenuvo makes proactive health screening seamless and more widely accessible. Combining high-quality technology with radiation-free and non-invasive imaging assessments, Prenuvo's patient-centric design is optimized to help assess the body holistically, providing individuals with a detailed overview of their health. Prenuvo's exclusively affiliated Radiology group partners consist of 100+ radiologists who help risk-stratify each patient report, keeping in mind healthcare complexities from the patient's perspective, the treating clinician's perspective, and the healthcare system's perspective.
Prenuvo currently operates in 26 clinics across North America, Australia, and Europe. To find your nearest Prenuvo, please visit here. Learn more at www.prenuvo.com and connect with Prenuvo here.
Media Contacts
Myocardial Solutions, Inc.
Jeanna Darino
Media Contact
Jeanna Darino, Myocardial Solutions, 1 919.677.8100, [email protected], https://myocardialsolutions.com/
SOURCE Myocardial Solutions
Share this article